Early aspirin discontinuation and transition to a P2Y12 inhibitor monotherapy may lower bleeding risk in those at low ...

Baxdrostat has shown significant reductions in blood pressure in patients with uncontrolled or treatment-resistant ...

Dr W. Keith Tan describes how a Barrett’s oesophagus capsule-sponge test offers precision risk stratification for oesophageal ...

Tackling cardiovascular complications from Covid-19 and long Covid is the subject of a new clinical consensus statement from ...

Women who don’t attend their first mammogram face a 40% higher risk of dying from breast cancer in the long-term.

An alarming rise in cases of magnet ingestion underscores the potentially severe consequences and the urgent need for preventive measures.

Profs Ravi Acharya and Edward Sturrock review the historical foundation, present landscape and future clinical promise of ACE inhibition.

The role of beta-blockers after myocardial infarction (MI) in patients with mildly reduced left ventricular ejection fraction (LVEF) is under debate, after new research was unveiled at the European ...

The use of artificial intelligence (AI) software has shown a 100% detection rate for melanoma and saved over 1,000 face-to-face secondary care consultations during a 10-month period, according to a ...

A consensus statement outlining strategies for the identification and management of cardiopulmonary risk in chronic obstructive pulmonary disease has been developed by a global expert working group.

The cystic fibrosis (CF) medication ivacaftor (brand name Kalydeco) is safe and effective in infants aged four weeks and over, paving the way for earlier initiation of therapy for newborns diagnosed ...

The rapidly developing area of technology and artificial intelligence (AI) within respiratory medicine and science was under the spotlight at this year’s European Respiratory Society (ERS) Congress, ...